Two Leiden researchers have been awarded ERC Proof of Concept grants. These grants, each worth EUR 150,000, will help the grantees in their efforts to bridge the gap from basic science to real-life applications

Isabelle Duyvesteyn, Professor of International Studies and Global History at the Institute of History and member of the advisory board of Leiden University’s Centre for International Relations (LUCIR) is widely regarded as an expert on civil wars and conflicts. Her new book, Rebels and Conflict Escalation,…

The war between Ukraine and Russia is playing out not just on the battlefield but also on the geopolitical playing field of gas. Conflicts at the start of this century about this energy source were, says PhD candidate Ilia Barboutev, a precursor to today’s war.

The war between Russia and Ukraine plays out not only physically but also digitally. Van Den Berg, Professor of Cybersecurity Governance at the FGGA, talked about it at several news outlets.

In a sailboat, a canoe or stowed away on a ship: during the Second World War, many Leiden students tried to cross the sea to join the Allies in Britain. ‘Soldier of Orange’ is the most famous, but who were the other ‘England voyagers’ or Engelandvaarders as they are known?

The Houthis are attacking ships in the Red Sea. Rerouting via South Africa is expensive, whereas the Arctic route only takes a week. Once a no-go zone, this route might be a more realistic option. Mind the nuclear submarines, though…

Francesca Albanese, UN Special Rapporteur for human rights in the occupied Palestinian territories, visited Leiden Law School on 8 December within the scope of International Human Rights Day.

President Zelensky of Ukraine has asked the UN International Court of Justice to issue an urgent order to stop Russian military activity in his country. According to Zelensky, Russia has twisted the concept of genocide to justify aggression.

Everyone has been watching the attack on Ukraine, a war on the European continent, with a sense of foreboding. It will bring devastation, loss, suffering and worry and it raises questions. With these words, Rector Magnificus Hester Bijl opened the meeting on the war in Ukraine at Wijnhaven on Thursday…

The AtheroNeth consortium received €6 million from the Dutch Heart Foundation to gain a better understanding of the differences in disease progression among patients with atherosclerosis. The ultimate goal is to enable personalised treatment.

With a €1.5 million European grant, industrial ecologist Stefano Cucurachi will work on more sustainable production methods for the pharmaceutical industry. The Italian company Angelini Pharma intends to use the resulting knowledge to make its production process more sustainable.

‘’ And then the world changed forever ,welcome to the future’’. These are the words that Kausik Ray (President of the European Atherosclerosis Society) spoke when the worldwide first dose of inclisiran, a novel SiRNA based cholesterol lowering agent, was administered at the Cardiology lipid clinic at…

Lecture

University Lecturer in History and International Studies Andrew Gawthorpe discusses on The Conversation the newly signed US-Ukraine economic partnership agreement.

In Dutch magazine De Psycholoog, Anne-Laura van Harmelen talks about the impact traumatic experiences, especially for those who are growing up.

On Tuesday 20 September, David Kilcullen, one of the world’s leading experts on modern warfare, visited Campus The Hague of Leiden University to discuss future developments in special operations and the escalating competition between great powers.

Four university medical centres, including the LUMC, are joining forces to increase pandemic preparedness in the Netherlands.

Symposium

'It gave our team a big boost to hear that our work was valuable,' says medical chemist Elmer Maurits about the moment they won the Venture Challenge. With their company Iprotics, they want to develop a drug that can better treat patients with autoimmune diseases and blood cancers. 25,000 euros of prize…

Why does a medicine work well for one person, but cause side effects in another? Research by Laura de Jong shows that it’s not just our DNA that matters – other medicines and illnesses can also affect how our bodies respond.

RARE-NL, a new collaboration between university hospitals, hopes to find treatments for rare diseases. Professor Teun van Gelder is representing the LUMC in the initiative.

Life returned to something resembling normal after Covid but other crises soon took its place. These great challenges are also being felt at the University and our researchers are working on solutions. The nitrogen crisis, problems with young people’s services and an increasingly urgent climate crisis:…

Chronic pain, nausea or vomiting due to chemotherapy. If you suffer from such ailments, medicinal cannabis can be a godsend. Though a downside is that it can make patients high. Therefore, Leiden researchers from the Oncode Institute are investigating alternatives that do not make you high. In Nature…

Leiden researcher Anne-Grete Märtson brought together a large number of studies to better understand antibiotic dosing in patients with obesity. The publication in a renowned medical journal has already garnered much positive reactions, Märtson says. ‘It’s high time researchers started sharing more…

Two consortia led by Leiden researchers have been awarded over one million euros by the Dutch Research Council and the Ministry of Health, Welfare and Sport to find solutions to antimicrobial resistance.

A Dutch consortium has received €6.7 million to accelerate the development of nanomedicines together with patients. Researchers from Leiden University play a key role in the project.

Jus post bellum, the body of laws and norms governing the transition from armed conflict to peace, has emerged as a crucial issue for international law scholars, governments, and all concerned with building a just and sustainable peace. The Jus Post Bellum Project, funded by the NWO and hosted by the…

How can you ensure that more experimental drugs reach the finish line? At the moment, only one in twenty cancer drugs that are tested on humans makes it to the market. This is an enormous loss for patients and society. With a grant from the National Growth Fund, Oncode-PACT aims to efficiently select…

PhD defence